Last updated: January 21, 2024
Sponsor: Mahidol University
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
StarWalker® PQX
Clinical Study ID
NCT06231914
Si 981/2023
Ages 40-55 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Aged 40-55 years
- BMI < 25 kg/m2
- Asian
- Mild to moderate facial skin laxity using quantitative grading scale (grade 1.5-2.5)
Exclusion
Exclusion Criteria:
- Pregnant or lactation
- Subjects who have been treated with any kind of energy-based device 6 months prior tothe inclusion
- Subjects who have been injected with botulinum toxin, filler, or platelet-rich plasmaon their faces 6 months prior to the inclusion
- Active skin infections
- History of hypertrophic scars or keloids
Study Design
Total Participants: 30
Treatment Group(s): 1
Primary Treatment: StarWalker® PQX
Phase:
Study Start date:
December 01, 2023
Estimated Completion Date:
March 01, 2025
Study Description
Connect with a study center
Department of Dermatology, Siriraj Hospital, Mahidol University
Bangkok, 10700
ThailandActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.